MANILA, Nov 4 (Mabuhay)– Almost all target recipients of COVID-19 vaccines in the National Capital Region (NCR) will be fully vaccinated by February next year, according to the Metropolitan Manila Development Authority (MMDA).
In a report to President Rodrigo Duterte aired Wednesday, MMDA chairperson Benhur Abalos said their projections showed 94.62% of the 9.8 million eligible population were due to complete the vaccination series by December 1.
This will then increase to 99.46% or 9,747,243 individuals by February 1, 2022.
The number of fully vaccinated individuals in the NCR stood at 87.69% of the target population or 8.59 million as of November 1.
On Wednesday, Health Undersecretary Myrna Cabotaje said the NCR was “very aggressive” and “very progressive” in its vaccination efforts.
“Na-develop na ‘yung tinatawag nating cadence, ‘yung practice nung ating mga mayors. ‘Pag may bakuna alam na nila sino ang babakunahan, ano ang schedule. Nag increase ng vaccination sites para ma-meet nila ‘yung target,” she said.
Cabotaje, who is also the chairperson of the National Vaccination Operations Center, issued the remark as she addressed the gap between the vaccine doses received by the country and those it has deployed.
She said the release of documents as well as the readiness of the areas to receive the vaccines are the factors that affect the distribution.
“‘Yung mga nandoon sa ating mga probinsya, dapat binababa. Bakit hindi tayo nakaka throughput? Kasi hindi nila jina-jab. Simula’t sapul ang ating prinsipyo, once you give the vaccine dapat in five days nai-jab na lahat ‘yan,” she said in a media briefing.
“But ang isang problema, hindi pa nakukuha ‘yung cadence. Ginawa kasi nilang business as usual,” she added.
She said some provinces needed to be pushed as they are unused to receiving a lot of vaccine doses.
Vaccine czar Carlito Galvez Jr. earlier said the government aims to administer one million to 1.5 million COVID-19 vaccine doses on a daily basis beginning November 20.
Cabotaje said the Philippines has so far received 108 million doses. Specifically, around 87 million doses have been deployed and more than 60 million doses have been administered to vaccine recipients. (MNS)